Mitogen-activated protein kinase activation is involved in platelet- derived growth factor-directed migration by vascular smooth muscle cells

Hypertension

Volumn 29, Issue 1 II, 1997, Pages 334-339

  Graf, Kristof ^a,b   Xi, Xiao Ping ^a   Yang, Dong ^a   Fleck, Eckart ^c   Hsueh, Willa A ^a   Law, Ronald E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c NONE

Author keywords

antisense oligodeoxynucleotide; MAP kinase; platelet derived growth factor; smooth muscle cell migration

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIUM ION; CHEMOATTRACTANT; LIPOSOME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CALCIUM TRANSPORT; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE;

EID: 0031033617     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.334     Document Type: Article

References (21)

1. Grotendorst G, Seppa H, Kleinman H, Martin G. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. PNAS. 1981;78:3669-3672.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
3. Bornfeldt K, Raines E, Nakano T, Graves L, Krebs E, Ross R. Insulin-like growth factor and PDGF-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest. 1994; 93:1266-1274.
4. Kundra V, Escobedo J, Kazlauskas A, Kim H, Rhee S, Williams L, Zetter B. Regulation of chemotaxis by the platelet-derived growth factor receptor-β. Nature. 1994;367:474-476.
5. Ferns G, Raines E, Sprugel K, Montani A, Reidy M, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty with an antibody to PDGF. Science. 1991;253:1129-1132.
6. Jawien A, Bowen-Pope D, Lindner V, Schwartz S, Clowes A. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
7. Bilato C, Pauly R, Melillo G, Monticone R, Gorelick-Feldmann D, Gluzband Y, Sollott S, Lakatta E, Crow M. Intracellular signaling pathways are required for rat vascular smooth muscle cell migration. J Clin invest. 1995;96:1905-1915.
8. Kundra V, Anand-Apte B, Feig L, Zetter B. The chemotactic response to PDGF-BB: evidence for a role for RAS. J Cell Biol. 1995;130:725-731.
9. Zhan X, Goldfarb M. Growth factor requirements of oncogene transformed NIH 3T3 and BALB/c3T3 cells cultured in defined media. Mol Cell Biol. 1986;6:3541-3544.
10. Chamley-Campbell J, Campbell G, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
11. Law RE, Meehan PW, Xi X, Graf K, Wuthrich D, Coats W, Faxon D, Hsueh AW. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest. 1996;98:1897-1905.
12. Sale E, Atkinson P, Sale G. The requirement of MAP kinase for the differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 1995;14:674-684.
13. Glennon P, Kaddoura S, Sale E, Sale G, Fuller S, Sugden P. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylepinephrine-induced hypertrophic response in rat cardiac myocyte. Circ Res. 1996;78:954-961.
14. Nabika T, Velletri P, Lovenberg W, Beaven M. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [arg] vasopressin in vascular smooth cells. J Biol Chem. 1985; 260:4661-4670.
15. Dudley D, Pang L, Decker S, Bridges A, Saltiel A. A synthetic inhibitor of the mitogen-activated protein kinase cascade. PNAS. 1995; 92:7686-7689.
16. Servant M, Giasson E, Meloche S. Inhibition of growth factor-induced protein synthesis by a selective inhibitor in aortic smooth muscle cells. J Biol Chem. 1996;271:16047-16052.
17. Pickering JG, Isner JM, Ford CM, Weir L, Lazarovits A, Rocnik EF, Chow LH. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Circulation. 1996;93:772-780.
18. Ray L, Sturgill T. Characterization of insulin-stimulated microtubule associated protein kinase: rapid isolation and stabilization of a novel serine/threonine kinase from 3T3-L1 cells. J Biol Chem. 1988;263: 12721-12727.
19. Lazar D, Wiese R, Brady M, Mastick C, Waters S, Yamauchi K, Pessin J, Cuatrecasas P, Saltiel A. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem. 1995;270:20801-20807.
20. Chao TO, Byron KL, Lee KM, Villareal M, Rosner MR. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J Biol Chem. 1992;267:19876-19883.
21. Pang L, Sawada T, Decker S, Saltiel A. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem. 1995;270:13585-13588.